© 2002 Wiley Periodicals, Inc.
The next generation of antibiotics could greatly benefit medicine, many researchers say. It also could, some warn, be quite dangerous. Prompting this debate is a class of drugs based on antimicrobial peptides that all animals and plants produce to fight infections. Studies over the past 15 years have found that these peptides, called AMPs, are powerful germ-killers.
But their most remarkable property, proponents say, is that they rarely spur the evolution of resistant microorganisms....
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?